These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11897936)

  • 1. What should we do with aspirin, NSAIDs, and glycoprotein-receptor inhibitors?
    Russell MW; Jobes D
    Int Anesthesiol Clin; 2002; 40(2):63-76. PubMed ID: 11897936
    [No Abstract]   [Full Text] [Related]  

  • 2. Difficult endoscopic hemostasis of post-sphincterotomy bleeding--look beyond aspirin and NSAIDs.
    Girotra M; Abraham RR; Rabine JC; Dutta SK
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):e73-4. PubMed ID: 23498773
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease.
    Lefkovits J; Topol EJ
    Eur Heart J; 1996 Jan; 17(1):9-18. PubMed ID: 8682137
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
    Konstantopoulos K; Mousa SA
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1086-92. PubMed ID: 11892918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a bleeding problem with platelet-active drugs?
    Kövesi T; Royston D
    Br J Anaesth; 2002 Feb; 88(2):159-63. PubMed ID: 11878649
    [No Abstract]   [Full Text] [Related]  

  • 6. Relation of platelet inactivation with intravenous glycoprotein IIb/IIIa antagonists to major bleeding (from the GOLD study).
    Tamberella MR; Bhatt DL; Chew DP; Kereiakes DJ; Topol EJ; Steinhubl SR;
    Am J Cardiol; 2002 Jun; 89(12):1429-31. PubMed ID: 12062743
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
    Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do aspirin and non-steroidal anti-inflammatory drugs increase the risk of post-sphincterotomy hemorrhage--a case-control study.
    Onal IK; Parlak E; Akdogan M; Yesil Y; Kuran SO; Kurt M; Disibeyaz S; Ozturk E; Odemis B
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):171-6. PubMed ID: 22677232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of alphaII(b)beta3 activation by non-steroidal antiinflammatory drugs.
    Domínguez-Jiménez C; Díaz-González F; González-Alvaro I; Cesar JM; Sánchez-Madrid F
    FEBS Lett; 1999 Mar; 446(2-3):318-22. PubMed ID: 10100866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current developments in anti-platelet therapy.
    Mayr FB; Jilma B
    Wien Med Wochenschr; 2006 Sep; 156(17-18):472-80. PubMed ID: 17041802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological control of platelet function.
    Clutton P; Folts JD; Freedman JE
    Pharmacol Res; 2001 Oct; 44(4):255-64. PubMed ID: 11592859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of platelet-altering medications on bleeding from minor oral surgery procedures.
    Partridge CG; Campbell JH; Alvarado F
    J Oral Maxillofac Surg; 2008 Jan; 66(1):93-7. PubMed ID: 18083421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological approaches to studying platelet function: an overview.
    Hourani SM
    Methods Mol Biol; 2004; 273():73-86. PubMed ID: 15308794
    [No Abstract]   [Full Text] [Related]  

  • 14. Glycoprotein IIb/IIIa integrin blockade.
    Madan M; Berkowitz SD; Tcheng JE
    Circulation; 1998 Dec; 98(23):2629-35. PubMed ID: 9843473
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation.
    Nannizzi-Alaimo L; Alves VL; Phillips DR
    Circulation; 2003 Mar; 107(8):1123-8. PubMed ID: 12615789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the glycoprotein IIb/IIIa antagonist abciximab on thrombus formation and platelet function in cats with arterial injury.
    Bright JM; Dowers K; Powers BE
    Vet Ther; 2003; 4(1):35-46. PubMed ID: 12756634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical implications of platelet glycoprotein IIb-IIIa inhibition.
    Duke C; Grammie JS
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):1083-4. PubMed ID: 9832706
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
    Judge HM; Buckland RJ; Holgate CE; Storey RF
    Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nonsteroidal anti-inflammatory therapy on platelets.
    Schafer AI
    Am J Med; 1999 May; 106(5B):25S-36S. PubMed ID: 10390125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein IIb/IIIa inhibitors, surgery and bleeding.
    Aylward P
    Aust N Z J Med; 1998 Oct; 28(5):583-4. PubMed ID: 9847944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.